Chongqing Zhifei Biological Products Co., Ltd. (SZSE: 300122)
Health Care · Biotechnology · CN
CN¥13.70
-2.00% today · -33.5% 1Y
Chongqing Zhifei Biological Products Co., Ltd. (SZSE: 300122) operates in the Biotechnology industry within the Health Care sector. The company is valued at $4.90B and employs 6,292 people.
Over the last twelve months the share price has lost 33.5%, trading between 11.07 and 22.18.
Tweenvest scores Chongqing Zhifei Biological Products Co., Ltd. across four factors: quality 68/100, value 51/100, growth 62/100. Its strongest factor is quality.
300122 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $4.90B
- Revenue (TTM)
- $1.19B
- P/E
- —
- EPS
- -6.24
- Dividend yield
- —
- Beta (5Y)
- 0.44
- 52-week high
- CN¥22.18
- 52-week low
- CN¥11.07
- Avg volume (3M)
- —
- Shares outstanding
- 2.39B
- Employees
- 6,292
- Next earnings
- —
About Chongqing Zhifei Biological Products Co., Ltd.
Chongqing Zhifei Biological Products Co., Ltd. is a Chinese firm primarily engaged in the innovation, manufacturing, and commercialization of vaccines and other biological pharmaceuticals within the country. The company's establishment dates back to 2009, and its main operational base is located in Chongqing, China.
- ISIN
- CNE100000V20
- Founded
- 2002
- Listed since
- Sep 28, 2010
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Sunshine Guojian Pharmaceutical (Shanghai) Co., LtdSHSE: 688336 | $5.10B | CN¥38.10 | -8.04% |
| Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.SHSE: 603392 | $5.09B | CN¥26.96 | -1.39% |
| Shanghai RAAS Blood Products Co., Ltd.SZSE: 002252 | $4.98B | CN¥5.06 | -4.89% |
| Travere Therapeutics, Inc.NasdaqGM: TVTX | $4.91B | $52.79 | +1.28% |
| 3SBio Inc.SEHK: 1530 | $4.79B | HK$15.07 | +0.53% |
| Dianthus Therapeutics, Inc.NasdaqCM: DNTH | $4.61B | $83.01 | +0.78% |
| Lin BioScience, Inc.TPEX: 6696 | $4.54B | NT$175.00 | -3.58% |
| Shanghai Junshi Biosciences Co., Ltd.SEHK: 1877 | $4.45B | HK$17.65 | -2.32% |
Figures last refreshed Oct 11, 2026.